TRxADE HEALTH, Inc. (NASDAQ:MEDS – Get Free Report)’s share price was down 3.8% during mid-day trading on Wednesday . The stock traded as low as $7.25 and last traded at $7.28. Approximately 9,199 shares were traded during mid-day trading, a decline of 96% from the average daily volume of 221,337 shares. The stock had previously closed at $7.57.
TRxADE HEALTH Trading Down 3.8 %
The firm’s fifty day moving average price is $11.47 and its two-hundred day moving average price is $10.42.
TRxADE HEALTH (NASDAQ:MEDS – Get Free Report) last posted its quarterly earnings results on Friday, August 9th. The company reported ($1.04) earnings per share for the quarter. TRxADE HEALTH had a negative return on equity of 198.55% and a negative net margin of 149.81%. The firm had revenue of $0.02 million during the quarter.
TRxADE HEALTH Cuts Dividend
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in TRxADE HEALTH stock. Virtu Financial LLC bought a new stake in shares of TRxADE HEALTH, Inc. (NASDAQ:MEDS – Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 10,617 shares of the company’s stock, valued at approximately $109,000. Virtu Financial LLC owned approximately 0.75% of TRxADE HEALTH at the end of the most recent reporting period. Institutional investors and hedge funds own 5.68% of the company’s stock.
About TRxADE HEALTH
TRxADE HEALTH, Inc operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace.
Further Reading
- Five stocks we like better than TRxADE HEALTH
- How to Invest in the FAANG Stocks
- Why Dick’s Could Be a Slam Dunk for Your Investment Portfolio
- Profitably Trade Stocks at 52-Week Highs
- Introduction to Fibonacci Retracement Levels
- Learn Technical Analysis Skills to Master the Stock Market
- Top 3 Stocks to Outperform the S&P 500 in a Downturn
Receive News & Ratings for TRxADE HEALTH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TRxADE HEALTH and related companies with MarketBeat.com's FREE daily email newsletter.